Toshiki Tasaki

发表

Whole-body bone marrow DWI correlates with age, anemia, and hematopoietic activity.

H. Okazawa, T. Tsujikawa, T. Yamauchi, 2019, European journal of radiology.

Induction of DNA strand breaks is critical to predict the cytotoxicity of gemtuzumab ozogamicin against leukemic cells

T. Yamauchi, T. Ueda, Y. Urasaki, 2012, Cancer science.

Prognostic effect of peripheral blood cell counts in advanced diffuse large B-cell lymphoma treated with R-CHOP-like chemotherapy: A single institution analysis

H. Iwasaki, T. Yamauchi, T. Ueda, 2014, Oncology letters.

Wilms' tumor-1 transcript in peripheral blood helps diagnose acute myeloid leukemia and myelodysplastic syndrome in patients with pancytopenia.

T. Yamauchi, N. Hosono, T. Ueda, 2012, Anticancer research.

Early relapse is associated with high serum soluble interleukin-2 receptor after the sixth cycle of R-CHOP chemotherapy in patients with advanced diffuse large B-cell lymphoma.

H. Iwasaki, T. Yamauchi, N. Hosono, 2012, Anticancer research.

High Risk of Tumor Lysis Syndrome in Symptomatic Patients with Multiple Myeloma with Renal Dysfunction Treated with Bortezomib.

T. Yamauchi, N. Hosono, T. Ueda, 2016, Anticancer research.

A nelarabine-resistant T-lymphoblastic leukemia CCRF-CEM variant cell line is cross-resistant to the purine nucleoside phosphorylase inhibitor forodesine.

T. Yamauchi, T. Ueda, Toshiki Tasaki, 2014, Anticancer research.

The response to induction therapy is crucial for the treatment outcomes of elderly patients with acute myeloid leukemia: single-institution experience.

H. Iwasaki, T. Yamauchi, Shin Lee, 2014, Anticancer research.

Quantitative Assessment of Bone Marrow Activity Using 18F-FLT PET in Aplastic Anemia and Myelodysplastic Syndromes

H. Okazawa, T. Tsujikawa, T. Yamauchi, 2022, Clinical nuclear medicine.

Successful treatment of disseminated intravascular coagulation by recombinant human soluble thrombomodulin in patients with acute myeloid leukemia

H. Iwasaki, T. Yamauchi, Kazuhiro Ito, 2018, Medicine.

A high serum uric acid level is associated with poor prognosis in patients with acute myeloid leukemia.

H. Iwasaki, T. Yamauchi, N. Hosono, 2013, Anticancer research.

Detectable Wilms' tumor-1 transcription at treatment completion is associated with poor prognosis of acute myeloid leukemia: a single institution's experience.

H. Iwasaki, T. Yamauchi, N. Hosono, 2013, Anticancer research.

18F-FLT PET/MRI for bone marrow failure syndrome-initial experience

H. Okazawa, P. Zanotti-Fregonara, T. Tsujikawa, 2019, EJNMMI Research.

3A Comparison between R-THP-COP and R-CHOP Regimens for the Treatment of Diffuse Large B-cell Lymphoma in Old Patients: A Single-institution Analysis

T. Yamauchi, N. Hosono, T. Ueda, 2017, Internal medicine.

counts) with early disease relapse following the attainment of complete remission (CR) by the rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP)-like regimen in patients with advanced diffuse large B-cell lymphoma

H. Iwasaki, T. Yamauchi, T. Ueda, 2014 .

Integrated [18F]FDG PET/MRI demonstrates the iron-related bone-marrow physiology

H. Okazawa, T. Tsujikawa, T. Yamauchi, 2020, Scientific Reports.

Successful Administration of Recombinant Human Soluble Thrombomodulin α (Recomodulin) for Disseminated Intravascular Coagulation during Induction Chemotherapy in an Elderly Patient with Acute Monoblastic Leukemia Involving the t(9;11)(p22;q23) MLL/AF9 Translocation

H. Iwasaki, T. Yamauchi, T. Ueda, 2011, Case reports in hematology.